Hyaluronic acid-based nanocarriers for intracellular targeting: Interfacial interactions with proteins in cancer

Research output: Contribution to journalArticlepeer-review

254 Scopus citations

Abstract

The therapeutic efficacy of most drugs is greatly depends on their ability to cross the cellular barrier and reach their intracellular target sites. To transport the drugs effectively through the cellular membrane and to deliver them into the intracellular environment, several interesting smart carrier systems based on both synthetic or natural polymers have been designed and developed. In recent years, hyaluronic acid (HA) has emerged as a promising candidate for intracellular delivery of various therapeutic and imaging agents because of its innate ability to recognize specific cellular receptors that overexpressed on diseased cells. The aim of this review is to highlight the significance of HA in cancer, and to explore the recent advances of HA-based drug carriers towards cancer imaging and therapeutics.

Original languageEnglish
Pages (from-to)82-94
Number of pages13
JournalColloids and Surfaces B: Biointerfaces
Volume99
DOIs
StatePublished - 1 Nov 2012

Keywords

  • Drug delivery
  • Hyaluronic acid
  • Intracellular targeting
  • Nanocarrier
  • Tumor imaging
  • Tumor targeting

Fingerprint

Dive into the research topics of 'Hyaluronic acid-based nanocarriers for intracellular targeting: Interfacial interactions with proteins in cancer'. Together they form a unique fingerprint.

Cite this